Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Cell Viability
10%
Combination Therapy
100%
Combined Therapy
10%
Development
10%
Drug Resistance
100%
In Vitro
20%
Leukemia
10%
Leukemia Cell
10%
Low Drug Dose
40%
Nilotinib
100%
Patient
20%
Philadelphia 1 Chromosome
10%
Prognosis
10%
Radiation
100%
Therapeutic Procedure
30%
Tyrosine-Kinase Inhibitor
30%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
100%
Clinical Outcome
10%
Combination Therapy
100%
Control
10%
Drug Resistance
100%
Experiment
10%
Low Drug Dose
40%
Nilotinib
100%
Philadelphia 1 Chromosome
10%
Procedures
100%
Prognosis
10%
Protein Tyrosine Kinase Inhibitor
30%
Biochemistry, Genetics and Molecular Biology
Cell Viability
10%
Development
10%
Drug Resistance
100%
Experiment
10%
Low Drug Dose
40%
Nilotinib
100%
Philadelphia Chromosome
10%
Radiation
100%
Tyrosine Kinase Inhibitor
30%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Chemotherapy
20%
Combination Therapy
20%
Drug Resistance
100%
Nilotinib
100%
Philadelphia 1 Chromosome
10%
Prognosis
10%
Protein Tyrosine Kinase Inhibitor
30%